Clinical Trial

Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia

Name: Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia — clinical trial record (NCT07516561)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: MONA

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the efficacy and safety of APSMNF in the treatment of male androgenetic alopecia.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-04-01.

Trial Details

NCT Number	NCT07516561
Lead Sponsor	Apsen Farmaceutica S.A.
Conditions	Alopecia, Androgenetic
Enrollment	336 participants
Start Date	2026-07-07
Primary Completion	2029-08-02 (estimated)
Study Completion	2029-08-02 (estimated)
Updated on ClinicalTrials.gov	2026-04-13